Literature DB >> 15218997

Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.

K De Boeck1, A Malfroot, L Van Schil, P Lebecque, C Knoop, J R W Govan, C Doherty, S Laevens, P Vandamme.   

Abstract

In Belgian cystic fibrosis (CF) clinics, sputum samples are evaluated on selective MAST medium routinely every 3 months. In this study, in 1993 and 1999, isolates were further examined by recA restriction fragment length polymorphism analysis and pulsed-field gel electrophoresis of genomic DNA restricted with SpeI. In 1993, 12 patients were colonised with Burkholderia cepacia complex (Bcc): B. cenocepacia (n=6), B. multivorans (n=3), B. stabilis (n=3). Four patients were colonised with the same B. cenocepacia strain; two with the same B. stabilis strain. After 5 yrs, three B. cenocepacia- and one B. multivorans-colonised patients had died. In 1999, Bcc was isolated in 12 patients: B. multivorans (n=9), B. stabilis (n=1) and B. cenocepacia (n=2). Three patients were colonised by the same B. multivorans strain. Compared to matched controls, the 5 yr outcome was poor; four B. cepacia patients died and none of the control patients died. Lung-function evolution was poor. In conclusion, the rate of colonisation in Belgian cystic fibrosis patients is stable and low. Burkholderia cenocepacia was most prevalent in 1993; Burkholderia multivorans in 1999. The cross-infection rate is low. Three patients had transient colonisation. The impact of Burkholderia cepacia complex on morbidity in the Belgian cystic fibrosis population is high and not limited to Burkholderia cenocepacia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218997     DOI: 10.1183/09031936.04.00118804

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Authors:  S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

4.  Refractory Burkholderia cepacia bacteraemia from a consolidation pneumonia lasting more than 7 weeks, successfully treated with systemic antibiotics and nebulised meropenem.

Authors:  Bryan Albert Lim; Adelaine Lopez; Joseph Adrian Buensalido
Journal:  BMJ Case Rep       Date:  2019-08-02

5.  Burkholderia cenocepacia bacteremia without respiratory colonization in an adult intensive care unit: epidemiological and molecular investigation of an outbreak.

Authors:  M Katsiari; Z Roussou; K Tryfinopoulou; Ac Vatopoulos; Ed Platsouka; A Maguina
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

6.  Comparative metabolic systems analysis of pathogenic Burkholderia.

Authors:  Jennifer A Bartell; Phillip Yen; John J Varga; Joanna B Goldberg; Jason A Papin
Journal:  J Bacteriol       Date:  2013-10-25       Impact factor: 3.490

Review 7.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Alex Horsley; Andrew M Jones; Robert Lord
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

8.  Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review.

Authors:  Stephen Kirkby; Kimberly Novak; Karen McCoy
Journal:  Core Evid       Date:  2011-08-11

9.  Multilocus sequence typing breathes life into a microbial metagenome.

Authors:  Eshwar Mahenthiralingam; Adam Baldwin; Pavel Drevinek; Elke Vanlaere; Peter Vandamme; John J LiPuma; Chris G Dowson
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Robert Lord; Andrew M Jones; Alex Horsley
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.